English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2305]
News [5292]
Articles [130]
Editorials [4]
Conferences [158]
elearning [13]
Fighting brain cancer
Fighting brain cancer
Wnt signalling interpreted differently depending on the receiving cell and signal duration
Wnt signalling interpreted differently depending on the receiving cell and signal duration
Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers
Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic cancers
Survival of children with acute lymphatic leukaemia further increased
Survival of children with acute lymphatic leukaemia further increased
New approach to adoptive T-cell therapy shows promise for boosting immune response in ovarian cancer
New approach to adoptive T-cell therapy shows promise for boosting immune response in ovarian cancer
Cancer experts call for cancer care to be centred on patients rather than the commercial bottom-line
Cancer experts call for cancer care to be centred on patients rather than the commercial bottom-line
Olaparib shows added benefit for younger treatment-naive mCRPC patients
Olaparib shows added benefit for younger treatment-naive mCRPC patients
New study suggests combination therapy to prevent resistance to treatment in hormone responsive metastatic breast cancer patients
New study suggests combination therapy to prevent resistance to treatment in hormone responsive metastatic breast...
Efficient boron neutron capture therapy for brain tumour with novel boron carrier
Efficient boron neutron capture therapy for brain tumour with novel boron carrier
Oestrogen and PARP inhibitor combination for advanced ER+ breast cancer shows promise in preclinical models
Oestrogen and PARP inhibitor combination for advanced ER+ breast cancer shows promise in preclinical models
<1...8485868788...530>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top